Press "Enter" to skip to content

New patent for Teikoku Pharma drug DOCETAXEL

2
Copyright © DrugPatentWatch. Originally published at New patent for Teikoku Pharma drug DOCETAXEL

Annual Drug Patent Expirations for DOCETAXEL
Annual Drug Patent Expirations for DOCETAXEL

Docetaxel is a drug marketed by Accord Hlthcare, Actavis Llc, Amneal, Apotex Inc, Dfb Oncology Ltd, Dr Reddys Labs Ltd, Hong Kong, Hospira Inc, Ingenus Pharms Llc, Jiangsu Hengrui Med, Mylan Labs Ltd, Pfizer Labs, Sandoz, Shilpa Medicare Ltd, Teikoku Pharma, Teva Pharms Usa, and Sun Pharma Global and, and is included in twenty-one NDAs. It is available from twelve suppliers. There are three patents protecting this drug.

This drug has twenty-four patent family members in nineteen countries.

The generic ingredient in DOCETAXEL is docetaxel. Twelve suppliers are listed for this compound. Additional details are available on the docetaxel profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent for Teikoku Pharma drug DOCETAXEL
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions